Loading…
Makes cleaning and disinfecting products including Clorox bleach, Glad trash bags, Brita filters and Burt's Bees.
Makes cleaning and disinfecting products including Clorox bleach, Glad trash bags, Brita filters and Burt's Bees.
Sells through supermarkets, mass merchants and clubs, with Walmart its largest customer, and spends heavily on advertising to hold shelf space in categories where a few brands lead. Cat litter, Glad bags and Brita filters sit alongside the cleaning products.
Moat: narrow (brand, distribution). Iconic cleaning/disinfecting brand recognition with strong retail-shelf presence, though facing private-label pressure.
Headquarters: Oakland, California, US · Founded: 1913 · Employees: 9,200
Size Clorox (CLX) is a United States Consumer Staples company (Household/Personal Care) with a market value of $12.1B, the 688th largest of 3,117 United States companies the cockpit tracks. Shares closed at $99.96 on 6 Nov 2026.
Performance Over six months the shares gained 8.5%, against +16.2% for the median peer and -1.1% for the United States market (cap-weighted) — 8th lowest of 21 in its peer set.
Growth Revenue grew 6.3% over the last twelve months (peer median +7.5%); the operating margin is 14.2% (peer median 14.3%).
Valuation It trades at 17.4× forward earnings against a peer median of 24.5× (6th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 3% a year for seven years (Req g). Recent delivered growth is -2%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 7.1 points above its cost of capital (7.0% WACC).
Credit Clorox has 8 bonds outstanding ($4.00B), rated BBB by the agencies and trading like A- at a weighted spread of 69 bp.
Short interest Short interest is 8.5% of the free float (15 Oct 2026).
Next results Next results expected around 4 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | $7.20B | $6.72B | $7.10B | $7.09B | $7.39B |
| Revenue growth | — | -5% | 0% | -4% | — |
| Gross profit | $2.99B | $2.81B | $3.19B | $3.02B | $2.87B |
| EBITDA | $1.28B | $1.13B | $1.40B | $1.15B | $1.06B |
| Net income | $677M | $587M | $810M | $280M | $149M |
| Free cash flow | $453M | $405M | $761M | $483M | $930M |
| Capital expenditure | $209M | $207M | $220M | $212M | $228M |
| Total debt | $5.59B | $5.60B | $2.92B | $2.94B | $2.95B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Clorox CLX | $12.1B | +8% | +6% | 14% | 17.4× | 2.7% |
| Procter & Gamble PG | $383B | +13% | +4% | 24% | 23.4× | -0.3% |
| Church & Dwight CHD | $25.8B | +17% | +2% | 18% | 27.4× | 6.9% |
| Reckitt Benckiser RKT.L | $47.6B | +22% | -2% | 28% | 16.4× | 1.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CLX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +19.8% | +9.8% | 3rd highest of 21 |
| 6-month return | +8.5% | +16.2% | 8th lowest of 21 |
| Distance from 52-week high | -21.5% | -8.4% | 7th lowest of 21 |
| Revenue growth (TTM) | +6.3% | +7.5% | 11th highest of 21 |
| Operating margin | 14.2% | 14.3% | 11th highest of 21 |
| Forward P/E | 17.4× | 24.5× | 6th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 2.7% | 4.7% | 9th least demanding of 20 |
| Growth delivered (Del g) | -1.8% | +6.6% | lowest of 20 |
| Hurdle (Req g minus delivered) | +4.4 pp | -2.8 pp | 8th most demanding of 20 |
| ROIC minus cost of capital | +7.1 pp | +5.4 pp | 5th highest of 20 |
| EV / EBITDA | 13.8× | 15.9× | 8th cheapest of 18 |
| Net debt / EBITDA | 4.2× | -0.2× | most indebted of 19 |
| Bond spread | 69 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Clorox CLX | United States | $12.1B | +8% | +6% | 14% | 17.4× | 2.7% | -1.8% |
| Unicharm 8113.T | Japan | $12.1B | +15% | 0% | 12% | 24.5× | -2.0% | +5.4% |
| Marico MARICO.NS | India | $12.3B | +8% | +20% | 16% | 51.8× | 28.0% | +11.1% |
| Puig Brands PUIG.MC | Spain | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% | +11.7% |
| Shiseido 4911.T | Japan | $9.52B | +20% | +5% | 4% | 32.8× | 17.5% | +1.0% |
| Godrej Consumer Products GODREJCP.NS | India | $9.19B | -18% | +12% | 18% | 37.0× | 31.7% | +6.6% |
| Essity ESSITY-A.ST | Sweden | $19.9B | +17% | -2% | 12% | 15.4× | -3.3% | +2.6% |
| Beiersdorf BEI.DE | Germany | $20.4B | +21% | -2% | 12% | 22.6× | -2.3% | +7.0% |
| Dabur India DABUR.NS | India | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% | +6.6% |
| APR 278470.KS | South Korea | $7.04B | -40% | +119% | 23% | 17.4× | -1.4% | +47.3% |
| e.l.f. Beauty ELF | United States | $6.85B | +91% | +31% | 12% | 35.4× | 27.9% | +38.8% |
| Kao 4452.T | Japan | $21.8B | +33% | +6% | 10% | 24.4× | 1.5% | +4.1% |
| Amorepacific 090430.KS | South Korea | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% | -0.8% |
| Church & Dwight CHD | United States | $25.8B | +17% | +2% | 18% | 27.4× | 6.9% | +4.8% |
| Reynolds Consumer Products REYN | United States | $5.08B | +10% | +2% | 14% | 14.6× | -0.2% | +2.7% |
| DSM-Firmenich DSFIR.AS | Netherlands | $29.5B | +62% | -45% | 8% | 30.1× | 24.3% | +2.5% |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.92B | -28% | +32% | 31% | 15.0× | 4.7% | +41.1% |
| Cupid CUPID.NS | India | $4.83B | +158% | +122% | 34% | n/a | n/a | n/a |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.83B | -23% | +9% | 28% | 32.2× | 30.8% | +4.5% |
| Interparfums IPAR | United States | $4.34B | +43% | +3% | 17% | 29.0× | 10.9% | +22.5% |
| Rohto Pharmaceutical 4527.T | Japan | $3.97B | +17% | +10% | 12% | 16.7× | -2.1% | +13.7% |
Clorox has 8 bonds outstanding with $4.00B face value. The agencies rate it BBB; its bonds trade like A-. Weighted yield 5.29%, a spread of 69 bp over government bonds.